- Home
- Life Sciences
- Pharmaceutical
- Pharmaceutical Analysis & Statistics in Germany, May 2013 (p5)
Talk to Geoffrey
+1 718 618 4302
Search inside this page
Publication dates
Publishers
- Global Data (629)
- Global Markets Direct (69)
- Global Research & Data Services (10)
- Business Monitor International (240)
- GBI Research (8)
-
- Global Industry Analysts (1)
- Datamonitor (119)
- Timely Data Resources Inc. (46)
- MarketLine (27)
- VacZine Analytics Group Of Assay Advantage Ltd (13)
- Espicom Business Intelligence (12)
- Mintel (11)
- Global Industry Analyst (9)
- Euromonitor International (7)
- ICD Research (6)
- MarketLine Industry Guides (6)
- SCRIP Insights (6)
- MarketsandMarkets (4)
- ABMRG (3)
- Frost & Sullivan (3)
- World Market Intelligence Ltd (3)
- Obainfo (2)
- Barnes Reports (2)
- Canadean Ltd (2)
- Daedal Research (2)
- Firstword Pharma (2)
- Koncept Analytics (2)
- Plimsoll Publishing Ltd UK (2)
- RNCOS (2)
- Visiongain (2)
- IData Research, Inc. (2)
- Arena (1)
- Arrowhead (1)
- Aruvian's R'search (1)
- Bioseeker (1)
- Business Review (1)
- DrugPatentWatch - ThinkBiotech LLC (1)
- Industry Experts (1)
- Ken Research Private (1)
- Renub Research (1)
- Urch Publishing (1)
data types
Free Market Research Guides to Download
Pharmaceutical Analysis & Statistics in Germany, May 2013 (p5)
You might be interested in: therapeutics, cancer, drug, more »
» Purchase Premium Reports
121-160 of about 1 000 reports
Germany Poisonings, 70+ Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Germany
Germany Poisonings, 45-59 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Germany
Germany Poisonings, 15-29 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Germany
Germany Poisonings, 5-14 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Germany
Germany Poisonings, 60-69 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Germany
Germany Poisonings, 30-44 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Germany
Germany Poisonings, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Germany
Germany Poisonings, 5-14 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Germany
Germany Poisonings, 15-29 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Germany
Germany Poisonings, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Germany
Trelstar (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Trelstar (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Trelstar (Prostate Cancer) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : Australia, World, Canada, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom, Oceania
Firmagon (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Firmagon (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Firmagon (Prostate Cancer) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Jevtana (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Jevtana (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Jevtana (Prostate Cancer) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Provenge (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Provenge (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Provenge (Prostate Cancer) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Zytiga (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Zytiga (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Zytiga (Prostate Cancer) - Forecast and Market Analysis to ...
- Industries : Pathology
- Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Xtandi (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Xtandi (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Xtandi (Prostate Cancer) - Forecast and Market Analysis to ...
- Industries : Pathology
- Countries : World, Australia, United States, Canada, Spain, Italy, France, Germany, Japan, Europe, United Kingdom
Xgeva (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Xgeva (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Xgeva (Prostate Cancer) - Forecast and Market Analysis to 2022?. ...
- Industries : Pathology
- Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Zometa (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Zometa (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Zometa (Prostate Cancer) - Forecast and Market Analysis to ...
- Industries : Pathology
- Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Cabozantinib (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Cabozantinib (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Cabozantinib (Prostate Cancer) - Forecast and Market ...
- Industries : Pathology
- Countries : World, Canada, Spain, Italy, France, Germany, Japan, United States, Australia, Europe, United Kingdom
Custirsen Sodium (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Custirsen Sodium (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Custirsen Sodium (Prostate Cancer) - Forecast and ...
- Industries : Pathology
- Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Sprycel (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Sprycel (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Sprycel (Prostate Cancer) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Yervoy (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Yervoy (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Yervoy (Prostate Cancer) - Forecast and Market Analysis to ...
- Industries : Pathology
- Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Orteronel (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Orteronel (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Orteronel (Prostate Cancer) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Zoladex (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Zoladex (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Zoladex (Prostate Cancer) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Alpharadin (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Alpharadin (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Alpharadin (Prostate Cancer) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Lupron Depot (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Lupron Depot (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Lupron Depot (Prostate Cancer) - Forecast and Market ...
- Industries : Pathology
- Countries : Australia, World, Canada, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom, Oceania
Tasquinimod (Prostate Cancer) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- December 2012
- by Global Data
Tasquinimod (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Tasquinimod (Prostate Cancer) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
EpiCast Report: Colorectal Cancer Epidemiology Forecast to 2022
- $ 3 995
- Industry report
- December 2012
- by Global Data
EpiCast Report: Colorectal Cancer Epidemiology Forecast to 2022 Summary Colorectal cancer is the third most common cancer in men and second most common cancer in women. GlobalData's epidemiologists expect ...
- Industries : Pathology
- Countries : World, Spain, Italy, France, Germany, China, United States, United Kingdom, Japan, India, Europe
Metanomics Health GmbH - Product Pipeline Analysis
- $ 750
- Company report
- December 2012
- by Global Data
Summary Metanomics Health GmbH (Metanomics) offers metabolite profiles. It is a part of a BASF Group. The company focuses on biomarker identification and validation across various applications. Its metabolite ...
- Industries : Pathology
- Countries : Germany, United States, Canada, Belgium
LABiTec GmbH - Product Pipeline Analysis
- $ 750
- Company report
- December 2012
- by Global Data
Summary LAbor BioMedical Technologies GmbH (LABiTec) is a medical devices company. It focuses on the production, development and distribution of high quality and a efficient healthcare systems in field ...
- Industries : Drug Discovery and Development
- Countries : Germany
Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs
- $ 3 500
- Industry report
- December 2012
- by GBI Research
Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs Summary GBI Research, the leading business intelligence ...
- Industries : Generic Drug
- Countries : Europe, United States, World, Japan, Spain, Italy, France, Germany
Forecast: Pneumococcal Vaccines
- $ 11 400
- Industry report
- December 2012
- by Datamonitor
This patient-based pneumococcal vaccine forecast segments the market by brand and population groups eligible for vaccination across the US, Japan, and the five major EU markets (France, Germany, Italy, ...
- Industries : Drug and Medication
- Countries : Japan, United States, Netherlands, Spain, Italy, France, Germany, Europe, United Kingdom
OTC Medications - Germany (2012)
- $ 599
- Industry report
- December 2012
- by Mintel
OTC Medications in Germany by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers analgesics, cough/cold/flu, gastro-intestinal, ...
- Industries : Over-the-counter Drug
- Countries : Germany
Pharmaceuticals - Global Group of Eight (G8) Industry Guide, MarketLine Industry Guides
- $ 1 495
- Industry report
- December 2012
- by MarketLine Industry Guides
Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, ...
- Industries : Pharmaceutical
- Countries : United States, United Kingdom, Canada, Russian Federation, Italy, France, Germany, Japan, World, Europe
Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides
- $ 1 495
- Industry report
- December 2012
- by MarketLine Industry Guides
Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals: Global Industry Guide industry. It includes detailed data on market size and ...
- Industries : Pharmaceutical
- Countries : World, Europe, United States, United Kingdom, Netherlands, France, Germany, Japan, Canada, Spain, Italy, Belgium, China
Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides
- $ 1 495
- Industry report
- December 2012
- by MarketLine Industry Guides
Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals: Global Industry Guide industry. It includes detailed data on market size and ...
- Industries : Pharmaceutical
- Countries : World, Europe, United States, United Kingdom, Netherlands, France, Germany, Japan, Canada, Spain, Italy, Belgium, China
Pharmaceuticals - Global Group of Eight (G8) Industry Guide, MarketLine Industry Guides
- $ 1 495
- Industry report
- December 2012
- by MarketLine Industry Guides
Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, ...
- Industries : Pharmaceutical
- Countries : United States, United Kingdom, Canada, Russian Federation, Italy, France, Germany, Japan, World, Europe
PharmaPoint: Rheumatoid Arthritis - Germany Drug Forecast and Market Analysis Event-Driven Update
- $ 4 995
- Industry report
- November 2012
- by Global Data
PharmaPoint: Rheumatoid Arthritis - Germany Drug Forecast and Market Analysis Event-Driven Update Summary GlobalData has released its new Country report, ?PharmaPoint: Rheumatoid Arthritis - Germany ...
- Industries : Pathology
- Countries : Germany
Pharmaceuticals - World Market Group of Eight (G8) Market Overview (Market size, Segmentation and Trends Analysis)
- $ 1 495
- Industry report
- November 2012
- by MarketLine
The market research report includes easily comparable data on industry value, volume, key market segments and industry share, plus full 5 year industry forecasts . It examines future problems, innovations ...
- Industries : Pharmaceutical
- Countries : United States, United Kingdom, Canada, Russian Federation, Italy, France, Germany, Japan, World, Europe
Pharmaceuticals: World Market Overview (Market size, Segmentation and Trends Analysis)
- $ 1 495
- Industry report
- November 2012
- by MarketLine
It includes detailed data on industry size and sector ation, textual analysis of the key trends and competitive landscape, and profiles of the leading firms . This incisive report provides expert analysis ...
- Industries : Pharmaceutical
- Countries : World, Europe, United States, United Kingdom, Netherlands, France, Germany, Japan, Canada, Spain, Italy, Belgium, China
» Download Public Reports
About 400 reports
Company Report: Drug Discovery in France and Germany for Year 2013
- Company report
- April 2013
- 2 pages
... Health will drive forward public health knowledge, which is a key issue for all governments." The french-german advanced translational drug discovery center is a unique project of public- private ...
Allergy Therapeutics Plc - Annual Report 2012
December 2012Company Report: Pain Therapy In Germany For Year 2012
December 2012Sbi Holdings Inc. - Company Report For Year 2012
November 2012Global Pharmaceutical Sector Brief Analysis
February 2013Cancer Market In The United States And Germany
December 2012» Read our Company Profiles
23 CompaniesGlaxoSmithKline P.L.C.
United StatesNovartis Inc.
SwitzerlandGlaxoSmithKline PLC
United KingdomJohnson and Johnson
United StatesAstraZeneca PLC
United KingdomReportlinker.com © Copyright 2013. All rights reserved.
